AllianceBernstein’s MaxCyte MXCT Stock Holding History

AllianceBernstein’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$155K	Hold	100,100	–	–	﹤0.01%	3101
2025 Q4	$155K	Hold	100,100	–	–	﹤0.01%	3109
2025 Q3	$158K	Hold	100,100	–	–	﹤0.01%	3129
2025 Q2	$218K	Buy	100,100 +15,100	+18%	+$36.6K	﹤0.01%	3025
2025 Q1	$232K	Hold	85,000	–	–	﹤0.01%	2878
2024 Q4	$354K	Hold	85,000	–	–	﹤0.01%	2791
2024 Q3	$331K	Hold	85,000	–	–	﹤0.01%	2871
2024 Q2	$333K	Buy	85,000 +21,910	+35%	+$94.3K	﹤0.01%	2874
2024 Q1	$264K	Hold	63,090	–	–	﹤0.01%	2847
2023 Q4	$297K	Sell	63,090 -4,530	-7%	-$17.6K	﹤0.01%	2850
2023 Q3	$211K	Buy	67,620 +6,030	+10%	+$24.2K	﹤0.01%	2941
2023 Q2	$283K	Buy	61,590 +20,390	+49%	+$93.7K	﹤0.01%	2889
2023 Q1	$204K	Buy	41,200 +6,200	+18%	+$30.5K	﹤0.01%	2900
2022 Q4	$191K	Buy	35,000 +17,000	+94%	+$104K	﹤0.01%	3019
2022 Q3	$117K	Buy	18,000 +6,400	+55%	+$35.7K	﹤0.01%	3104
2022 Q2	$55K	Buy	+11,600	New	+$57.1K	﹤0.01%	3167

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

AllianceBernstein's MXCT Position: Q1 2026 in Review

AllianceBernstein held its MaxCyte (MXCT) position steady in Q1 2026 at 100,100 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #3101.

AllianceBernstein first reported a position in MXCT in Q2 2022 and has held it in 16 quarters since. The position peaked at $354K in Q4 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

AllianceBernstein held 100,100 shares of MaxCyte worth $155K as of Q1 2026.
AllianceBernstein left its MaxCyte share count unchanged in Q1 2026.
MaxCyte made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3101 holding.
AllianceBernstein first reported a position in MaxCyte in Q2 2022 and has held it in 16 quarters since.
AllianceBernstein's MaxCyte position peaked at $354K in Q4 2024.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.